Muutke küpsiste eelistusi

Novel Approaches in Metronomic Chemotherapy for Breast Cancer Treatment [Kõva köide]

Edited by
  • Formaat: Hardback, 208 pages, kõrgus x laius: 254x178 mm, kaal: 453 g, 20 Tables, black and white; 42 Line drawings, color; 42 Illustrations, color
  • Ilmumisaeg: 28-May-2024
  • Kirjastus: CRC Press
  • ISBN-10: 1032620455
  • ISBN-13: 9781032620459
Teised raamatud teemal:
Novel Approaches in Metronomic Chemotherapy for Breast Cancer TreatmentSuurem pilt
  • Formaat: Hardback, 208 pages, kõrgus x laius: 254x178 mm, kaal: 453 g, 20 Tables, black and white; 42 Line drawings, color; 42 Illustrations, color
  • Ilmumisaeg: 28-May-2024
  • Kirjastus: CRC Press
  • ISBN-10: 1032620455
  • ISBN-13: 9781032620459
Teised raamatud teemal:
Püsilink: https://www.kriso.ee/db/9781032620459.html
Märksõnad:

This book provides latest research and developments in the field of metronomic chemotherapy for breast cancer. It presents the principles and mechanisms of metronomic chemotherapy, preclinical and clinical studies, and the latest developments in drug delivery systems and nano formulations.



This book provides latest research and developments in the field of metronomic chemotherapy for breast cancer. It presents the principles and mechanisms of metronomic chemotherapy, preclinical and clinical studies, and the latest developments in drug delivery systems and nano formulations. The clinical pharmacology of metronomic chemotherapy including pharmacokinetics, pharmacogenetics, pharmacoeconomics, and adverse drug reactions are also examined.

Key Features –

  • Introduces metronomics therapy in the neoadjuvant and adjuvant treatment of breast cancer
  • Explores potential of metronomics towards personalized chemotherapy
  • Present pharmacological bases of metronomic chemotherapy
  • Covers latest developments in drug delivery systems, nanotechnology, and nano formulations
  • Discusses antiangiogenic effects and impact of metronomics on immunity

This book is useful for students, researchers, oncologists, pharmacologists, and healthcare experts interested in understanding the clinical potential of metronomic chemotherapy in breast cancer.

Chapter 1 Introduction to metronomic chemotherapy

Chapter 2 Metronomic chemotherapy- a multi-targeted therapy

Chapter 3 Conventional chemotherapeutic vs. metronomic chemotherapy

Chapter 4 The anti-angiogenic basis of metronomic chemotherapy

Chapter 5 Imaging techniques, biomarkers, and methods for metronomic chemotherapy

Chapter 6 Metronomic chemotherapy in breast cancer

Chapter 7 Metronomic chemotherapy in combination with anticancer vaccines

Chapter 8 Metronomic: towards personalized chemotherapy

Chapter 9 Metronomic chemotherapy for metastatic breast cancer

Chapter 10 Recent Advances, challenges, and future of metronomic chemotherapy

Chapter 11 Targeted therapies in combination with metronomic chemotherapy

Chapter 12 Recent advances in metronomic chemotherapy: nanotechnology-based low-dose chemotherapy in breast cancer

Index

Dr. Manzoor Ahmad Mir holds Masters Degree in Zoology with Gold Medal from HNBG Central University and after qualifying prestigious National level CSIR-JRF-NET examination; he worked jointly for his PhD at Jawaharlal Nehru University New Delhi and CSIR-Institute of Microbial Technology Chandigarh in the field of Immunopathology. His basic research interests include, molecular immunology and Immunobiology of microbes (MTB). His PhD research title was Role of co-stimulation in the survival of intracellular pathogens. He currently teaches Cancer Biology, and Immunology at the Department of Bioresources, School of Biological Sciences, University of Kashmir. He is presently heading the Department of Bioresources, University of Kashmir.